Contract Pharma: “CEO Spotlight: Pierre Luzeau on Seqens U.S. R&D Lab Investment Luzeau discusses expansion into U.S. markets, outsourcing trends, and the company’s plan for continued growth in the CDMO space” Feb. 6, 2023)